Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2026-01-10 @ 2:37 PM
Study NCT ID:
NCT04907851
Status:
COMPLETED
Last Update Posted:
2025-03-17
First Post:
2021-05-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2)
Sponsor:
Redx Pharma Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RXC004/0003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |